Soluble type II interleukin-1 receptors and methods

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 691, 530350, A01N 3718

Patent

active

057670641

ABSTRACT:
Type II IL-1 receptor (type II IL-1R) proteins, DNAs and expression vectors encoding type II IL-1R, and processes for producing type II IL-1R as products of recombinant cell culture, are disclosed. Also disclosed are compositions and methods for regulating an IL-1 mediated immune or inflammatory response in a mammal.

REFERENCES:
patent: 4675285 (1987-06-01), Clark et al.
Symons and Duff, FEBS Letters 272:133; 1990.
Dower et al., Nature (London) 324:263 (1986).
Sims et al., Science 241: 585 (1988).
Sims et al., Proc. Natl. Acad. Sci. USA 86: 8946 (1989).
Matsushima et al., J. Immunol. 136: 4496 (1986).
Horuk et al., J. Biol. Chem. 262:16275 (1987).
Rhyne et al., Clin. Immunol. and Immunopathol. 48: 354 (1988).
Tanaka et al., J. Immunol. 142: 167 (1989.
Bomsztyk et al., J. Biol. Chem. 264: 6052 (1989).
Scapigliati et al., FEBS Letters 243: 394 (1989).
Bensimon et al., J. Immunol. 142:2290 (1989).
Bensimon et al., J. Immunol. 143:1168 (1989).
Bomsztyk et al., Proc. Natl. Acad. Sci. USA 86: 8034 (1989).
Chizzonite et al., Proc. Natl. Acad. Sci. USA 86: 8029 (1989).
Mizuno et al., FEBS Letters 257: 27 (1989).
Savage et al., Cytokine 1: 23 (1989).
Horuk et al., Biochem. J. 260: 657 (1989).
Solari, Cytokine 2: 21 (1990).
Eastgate et al., FEBS Letters 260: 213 (1990).
Benjamin et al., Blood 75: 2017 (1990).
Okayama and Berg, Mol. Cell. Biol. 2:161 (1982).
Okayama and Berg, Mol. Cell. Biol. 3:280 (1983).
Aruffo and Seed, Proc. Natl. Acad. Sci. USA 84:8573 (1987).
Yamasaki et al., Science 241:825 (1988).
Yates et al., Proc. Natl. Acad. Sci. USA 81: 3806, (1984).
Lupton et al., Mol. Cell. Biol. 5: 2533 (1985).
Pfitzner et al., J. Virol. 61: 2902 (1987).
Klemenz et al., Proc. Natl. Acad. Sci. USA 86: 5708 (1989).
Tominaga, FEBS Letters 258: 301 (1989).
Fearon et al., Science 247: 49 (1990).
Gearing et al., EMBO 8:3367 (1989).
Giri et al., J. Biol. Chem. 265:17416-17419 (1990).
Smith et al. Science 238:1704-07 (1987).
Sims et al. Proc. Natl. Acad. Sci. USA 90:6155-6159 (1993).
Colotta et al. Science 261:472-475 (1993).
Leonard et al., Nature 311:676 (1984).
Belyavsky et al., Nucl. Acids Res. 17:2919 (1989).
Treiger et al., J. Immunol. 136:4099 (1986).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Soluble type II interleukin-1 receptors and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Soluble type II interleukin-1 receptors and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble type II interleukin-1 receptors and methods will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1725991

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.